prostate cancer studies - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera

Representative image of Infosys’ Bengaluru headquarters, highlighting its AI-driven IT services leadership and large deal momentum in Q1 FY26.

Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market

MGM Resorts International launches all-inclusive Las Vegas Strip package as resort operators chase value-conscious travel demand

The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice

Representative image of Asia’s fuel crisis deepening as the Philippines declares an energy emergency after Strait of Hormuz shipping disruptions raised fears over regional oil supply and fuel availability.

Asia’s fuel crisis deepens: Philippines declares emergency as Strait of Hormuz shipping collapses

ANGLE plc secures £550,000 deal with AstraZeneca to develop Parsortix-based Androgen Receptor detection assay, enhancing CTC prostate cancer research.

Read More

2 minute read

Healthcare Industry News

ANGLE plc signs deal with AstraZeneca to develop Parsortix-based AR detection assay for prostate cancer studies

In a deal valued at £550,000, ANGLE plc (AIM:AGL, OTCQX:ANPCY), a leading liquid biopsy company specializing in circulating…

byPallavi Madhiraju

May 4, 2024

web analytics